Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 13.7 USD -1.23% Market Closed
Market Cap: 973.4m USD
Have any thoughts about
Zymeworks Inc?
Write Note

Zymeworks Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zymeworks Inc
Other Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NASDAQ:ZYME
Other Equity
-$7.9m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Equity
-$2.5B
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
-20%
Gilead Sciences Inc
NASDAQ:GILD
Other Equity
$93m
CAGR 3-Years
32%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Equity
-$155m
CAGR 3-Years
44%
CAGR 5-Years
21%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Equity
$38m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Equity
-$69.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zymeworks Inc's Other Equity?
Other Equity
-7.9m USD

Based on the financial report for Jun 30, 2024, Zymeworks Inc's Other Equity amounts to -7.9m USD.

What is Zymeworks Inc's Other Equity growth rate?
Other Equity CAGR 5Y
-3%

Over the last year, the Other Equity growth was -1%. The average annual Other Equity growth rates for Zymeworks Inc have been -6% over the past three years , -3% over the past five years .

Back to Top